In summary, the involvement of NRG1 in promoting ERBB3-mediated signaling and the formation of oncogenic heterodimers with ERBB1, ERBB2, and ERBB4 highlights the significance of NRG1 fusions in driving abnormal cell proliferation and tumor progression. The gene discussed is ERBB4; the disease is neoplasm.